Partner Stan Fisher and associate Michael Liu recently authored the article “MDL Panels Will Play a Larger Role in Hatch-Waxman Litigation After 'Valeant'” for The Recorder. The article discusses the recent case, Valeant Pharmaceuticals North America v. Mylan Pharmaceuticals, in which the Federal Circuit resolved the question about venue in Hatch-Waxman cases. The court’s decision addressed a split among district courts on where ANDA filers could be sued, and although the impact of the decision may take time to realize, companies may face litigation in a greater number of courts across the country.
Click here to read the full article